新型冠状病毒肺炎流行期间免疫规划疫苗延迟接种安全性

doi:10.11852/zgetbjzz2020-0143

摘要/Abstract

摘要： 2019年12月以来,我国各地陆续发生新型冠状病毒肺炎(HCP)疫情。经国务院批准,国家卫生健康委于2020年1月20日决定将NCP纳入法定传染病乙类管理,采取甲类传染病的预防、控制措施。各地陆续采取病人隔离治疗、密切接触者隔离医学观察等系列防控措施。由于接种门诊可能导致人群聚集、增加病毒传播和感染的风险,儿童及其监护人存在隔离观察、隔离治疗的情况,都可能会导致儿童疫苗延迟接种。监护人和基层专业技术人员对于延迟接种的安全性、有效性及优先接种哪些疫苗的问题亟待释疑。近期中华预防医学会儿童保健分会组织专家,通过检索国内外大量文献,分析延迟接种对各种疫苗安全性和有效性的影响,希望尽可能减少儿童监护人和一线工作者对于延迟接种效果的困惑,为之后的疫苗补种提供科学依据和技术建议。

关键词: 免疫规划疫苗, 延迟接种, 安全性, 有效性, 儿童

Abstract: Since December 2019,an outbreak of novel coronavirus pneumia (NCP) has spread across China successively.Approved by the State Council,the National Health Commission of the People′s Republic of China has classified it into category-B infectious diseases in the list of the People′s Republic of China on the prevention and control of infectious diseases,and has regarded it as category-A infectious diseases in terms of the prevention and control measures on January 20th,2020.Successive series of prevention and control measures was conducted such as isolating patients and medical observation of their close contacts.The gathering of vaccination units may increase the risk of spread and infection of the NCP,so that children and their guardians are placed under home quarantine,which will results in delayed vaccination.Children′s guardians and health care staff in primary health care institutes are in great need of knowing the immunogenicity and safety of delayed vaccination and the priority of vaccination after recovery of outpatient service.On the basis of the literature review of guidelines and a large number of literature at home and abroad,experts of Group for Disease Prevention and Vaccination,Society of Child Health,Chinese Preventive Medicine Association analyzed the influence of all kinds of different inoculum time and procedures on the safety and immunogenicity of vaccination,hoping to provide scientific evidence and professional advice in time the and eliminate anxiety panic of child guardians and confusion of vaccination workers on the front line concurrently.

Key words: netional immunization program vaccines, delayed vaccination, safety, efficacy, children

中图分类号:

R725

王琳. 新型冠状病毒肺炎流行期间免疫规划疫苗延迟接种安全性[J]. 中国儿童保健杂志, 2020, 28(3): 242-246.

WANG Lin. Recommendations for delayed immunization with national immunization program vaccines based on safety and efficacy analysis during epidemic of novel coronavirus pneumonia[J]. Chinese Journal of Child Health Care, 2020, 28(3): 242-246.

参考文献

[1] Wang C,Horby PW,Hayden FG,et al.A novel coronavirus outbreak of global health concern[J].Lancet,2020,(published online Jan24).doi:https://doi.org/10.1016/S0140-6736(20)301 85-89.
[2] 全国人民代表大会常务委员会.中华人民共和国传染病防治法[Z].2013-6-29.
[3] 全国人民代表大会常务委员会.中华人民共和国疫苗管理法[Z].2019-6-29.
[4] 中华预防医学会,中华预防医学会疫苗与免疫分会.新型冠状病毒肺炎流行期间预防接种参考指引(第一版)[S].2020.
[5] 北京市疾控中心.新型冠状病毒感染的肺炎流行期间儿童预防接种防控指引(第一版)[S].2020.01.30.http://www.bjcdc.org/article/ztbd/2020/1/4028a8db6fbbc3bd016ff6864 8c80636.htm lfrom=timeline&isappinstalled=0.
[6] Kiely M,Boulianne N,Talbot D,et al.Children vaccination coverage surveys:Impact of multiple sources of information and multiple contact attempts[J].Vaccine,2020,38(5):1202-1210.
[7] Saroha M,Faridi M,Batra P,et al.Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants[J].Hum Vaccin Immunother,2015,11(12):2864-2871.
[8] Agladioglu S,Beyazova U,Camurdan AD,et al.Immunogenicity of recombinant hepatitis B vaccine:comparison of two different vaccination schedules[J].Infection,2010,38(4):269-273.
[9] 中国疾病预防控制中心免疫规划中心.国家免疫规划疫苗儿童免疫程序说明(2016年版)[S].2016.http://nip.chinacdc.cn/zstd/mycx/201807/t20180731_189375.htm.
[10] 北京市卫生健康委员会.新生儿卡介苗接种知情同意书[S].2018.
[11] Hesseling AC,Blakney AK,Jones CE,et al.Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants[J].Vaccine,2016,34(32):3702-3709.
[12] 北京市卫生和计划生育委员会.北京市免疫规划疫苗免疫程序及说明(2019年版)[S].2019.
[13] Das RR,Mathew JL,Ratho RK,et al.Randomized clinicaltrial comparing hepatitis B vaccine administered by 0,6,and 14 week versus 6,10,and 14 week schedule in healthy infants[J].J Trop Pediatr,2009,55:328-331.
[14] Nagano N,Kitajima H,Morioka I.Japanese original delayed hepatitis B vaccination provides adequate immunogenicity against mother-to-child hepatitis B virus infection in preterm infants:A nationwide survey in Japan[J].J Infect Chemother,2019.doi:10.1016/j.jiac.2019.11.007.
[15] 中国疾病预防控制中心.中国疾病预防控制中心关于印发脊髓灰质炎疫苗免疫策略调整技术方案的通知[S].2019.12.31.http://www.nhc.gov.cn/jkj/s3589 /202001/ba151e4ad7824ad6950d8d24879a2235.shtml.
[16] Grassly NC.Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine:systematic review and meta-analysis.[J].J Infect Dis,2014,210(Suppl 1):439-446.
[17] Swartz TA,Green MS,Handscher R,et al.Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel[J].Vaccine,2008,26(8):1083-1090.
[18] Carlsson R,Trollfors B.Control of pertussis–lessons lear nt from a 10-year surveillance programme in Sweden[J].Vaccine,2009,27:5709-5718.
[19] World Health Organization.百日咳疫苗:WHO 立场文件[J].Weekly Epidemiological Record,2010,40:385-400.doi:2010.https://www.who.int/immunization/documents/PP_Pertussis_oct2010_ZH.pdf?ua=1.
[20] Healy CM,Munoz FM,Rench MA,et al.Prevalence of pertussis antibodies in maternal delivery,cord,and infant serum[J].J Infect Dis,2004,190(2):335-340.
[21] 徐鹭,路坚,丁筱竹.南京市健康儿童流脑A群和C群抗体水平监测及A+C群流脑疫苗免疫效果分析[J].现代预防医学,2009,36(11):2048-2051.
[22] 闫绍宏,张洪飞,刘天英,等.冻干A+C群脑膜炎球菌多糖疫苗安全性和免疫原性观察[J].微生物学免疫学进展,2009,37(2):16-18.
[23] 刘鹏,邵茜,莫均.不同起始月龄麻疹类疫苗首剂接种抗体水平分析[J].预防医学情报杂志,2014,30(7):516-518.
[24] 严睿,何寒青,周洋,等.浙江省6～15岁儿童高浓度抗麻疹病毒抗体影响因素分析[J].浙江大学学报:医学版,2018,47(2):169-173.
[25] World Health Organization.Immunological basis for immunization:Measles (Update 2009)[S].2009.https://www.who.int/immunization/documents/ISBN9789241597555/ en/.
[26] Cáceres VM,Strebel PM,Sutter RW.Factors determining prevalence of maternal antibody to measles virus throughout infancy:a review[J].Clin Infect Dis,2000,31(1):110-119.
[27] Connor B,Bunn WB.The changing epidemiology of Japanese encephalitis and new data:the implications for new recommendations for Japanese encephalitis vaccine[J].Trop Dis Travel Med Vaccines,2017,3:14.
[28] 白智泳,赵广法,刘军.两种流行性乙型脑炎疫苗基础免疫的血清抗体观察[J].中国计划免疫,2000,6(4):16-17.
[29] 周本立,张岷,陈品全,等.流行性乙型脑炎活疫苗11年的流行病学效果[J].中国生物制品学杂志,2001,14(3):183-185.
[30] Jiang WP,Chen JT,Wang X,et al.Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive):a double-blind,randomized and controlled trial[J].Vaccine,2008,26(18):2297-2301.
[31] 张之伦,朱向军,王旭,等.甲型肝炎灭活疫苗和冻干减毒活疫苗接种后1年的免疫原性研究[J].中国病毒病杂志,2011,1(1):64-66.
[32] 任银海,陈江婷,吴文婷,等.孩尔来福甲型肝炎灭活疫苗不同免疫程序的评价[J].中国计划免疫,2003,9(4):219-221.
[33] 国家质量监督检验检疫总局.医用防护口罩技术要求[S].GB19083-2010,2011.
[34] 谢敬伟.各国口罩标准简论[J].科学与信息化,2019,(16):198.
[35] 姜毅,金润铭,郑跃杰,等.儿童新型冠状病毒感染诊断、治疗和预防专家共识(第一版)[J].中华实用儿科临床杂志,2020,35(2):81-85.
[36] 中国当代儿科杂志编辑委员会围产新生儿新型冠状病毒感染防控管理预案工作组,史源,富建华,等.围产新生儿新型冠状病毒感染防控管理预案(第一版)[J/OL].中国当代儿科杂志:1-4[2020-02-08].http://kns.cnki.net/kcms/detail/43.1301.r.20 200201.1820.006.html.